Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Electromyographic parameters in abnormal gait in patients suffering from amyotrophic lateral sclerosis
 
More details
Hide details
 
Submission date: 2018-07-16
 
 
Final revision date: 2018-10-17
 
 
Acceptance date: 2019-02-02
 
 
Publication date: 2019-03-30
 
 
Medical Studies 2019;35(1):23-31
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Amyotrophic lateral sclerosis (ALS) is a terminal neurodegenerative disease, which gradually damages motor neurons in the cortex, brainstem, and spinal cord, leading to a progressive deterioration in patients’ fitness and their dependence on others.

Aim of the research:
To assess electromyographic parameters and abnormal gait in the course of ALS.

Material and methods:
The study covered 20 people with clinically proven or probable ALS diagnosed, determined according to the El Escorial criteria. In the study group, 10 patients were affected by the limb onset of the disorder, and the remaining 10 people by the bulbar onset. The analysis covered electromyography and test results: 6-minute walk test and 10-metre walk test performed three times within 6 months.

Results:
The results of electromyographic parameters and tests were analysed for the whole group and separately for the group with bulbar-onset and limb-onset ALS. The statistical analysis of the results has shown that the duration of motor unit potential (MUP) is the most useful electromyographic parameter in early diagnosis and monitoring of the course of the disease. The increasing abnormal gait in the course of ALS was a clinical reflection of gradually prolonging MUP.

Conclusions:
The progressing loss of nerve and muscle function as a result of motor neuron loss is reflected in walking deterioration in ALS patients. 2. The gradually increasing MUP duration of particular muscles is concomitant to the increasing abnormal gait. The assessment of the MUP duration of particular muscles may serve to monitor the ALS progression.
REFERENCES (29)
1.
Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ , Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chio A, Hariman O, Moons KGM, Veldink JH, van den Berg LH. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 2018; 17: 423-433.
 
2.
Jawdat O, Statland JM, Barohn RJ, Katz JS, Dimachkie MM. Amyotrophic lateral sclerosis regional variants (brachial amyotrophic diplegia, leg amyotrophic diplegia, and isolated bulbar amyotrophic lateral sclerosis). Neurol Clin 2015; 33: 775-785.
 
3.
Turner MR, Hardiman O, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Show PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC. Controversies and priorities in amyotrophic lateral sclerosis. Lancet 2013; 12: 310-322.
 
4.
Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009; 4: 3.
 
5.
Gale C. Assisting patients with motor neurone disease to make decisions about their care. Int J Palliat Nurs 2015; 21: 251-255.
 
6.
Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007; 369: 2031-2041.
 
7.
Bäumer D, Talbot K, Turner MR. Advances in motor neuron disease. J R Soc Med 2014; 107: 14-21.
 
8.
Ferguson TA, Elman LB. Clinical presentation and diagnosis of amyotrophic lateral sclerosis. Neurorehabilitation 2007; 22: 409-416.
 
9.
de Carvalho M, Johnsen B, Fuqlsanq-Frideriksen A. Medical technology assessment. Electrodiagnosis in motor neuron diseases and amyotrophic lateral sclerosis. Neurophysiol Clin 2001; 31: 341-348.
 
10.
Lenglet T, Camolessanche JP. Amyotrophic lateral sclerosis or not: keys for the diagnosis. Rev Neurol (Paris) 2017; 173: 280-287.
 
11.
Banach M, Rakowicz M. Electrophysiological diagnosis of amyotrophic lateral sclerosis. Przegl Lek 2010; 67: 736-740.
 
12.
Vial C. What are the clinical criteria of amyotrophic lateral sclerosis by clinical form? Rev Neurol (Paris) 2006; 162: 4S25-4S28.
 
13.
Duleep A, Shefner J. Electrodiagnosis of motor neuron disease. Phys Med Rehabil Clin N Am 2013; 24: 139-151.
 
14.
Joyce NC, Carter GT. Electrodiagnosis in persons with amyotrophic lateral sclerosis. PMR 2013; 5 (Suppl 1): 89-95.
 
15.
Inghilleri M, Iacovelli E. Clinical neurophysiology in ALS. Arch Ital Biol 2011; 149: 57-63.
 
16.
Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the ’Awaji’ electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler 2010; 11: 497-501.
 
17.
Jensen L, Djurtoft JB, Bech RD, Nielsen JL, Jorgense LH, Schroder HD, Frandsen U, Aaqaard P, Hvid LG. Influence of resistance training on neuromuscular function and physical capacity in ALS patients. J Neurodegener Dis 2017; 2017: 1436519.
 
18.
Couratier P, Torny F, Lacoste M. Functional rating scales for amyotrophic lateral sclerosis. Rev Neurol (Paris) 2006; 162: 502-507.
 
19.
Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
 
20.
Lorenz DJ, Datta S, Harkema SJ. Longitudinal patterns of functional recovery in patients with incomplete spinal cord injury receiving activity-based rehabilitation. Arch Phys Med Rehabil 2012; 93: 1541-1552.
 
21.
Ren YT, Cui F, Yang F, Chen ZH, Ling L, Huang XS. Needle electromyography features and value of paraspinal muscle parameters in assessment of respiratory function of patients with amyotrophic lateral sclerosis. Zhonghua Yi Xue Za Zhi 2016; 96: 2616-2619.
 
22.
Xu Y, Zheng J, Zhang S, Kang D, Zhang J, Fan D. Needle electromyography of the rectus abdominis in patients with amyotrophic lateral sclerosis. Muscle Nerve 2007; 35: 383-385.
 
23.
Benaim C, Desnuelle C, Fournier-Mehouas M. Functional scales and motor assessment in amyotrophic lateral sclerosis. Rev Neurol (Paris) 2006; 162: 4S131-4S137.
 
24.
Murray L, Butow PN. Advance care planning in motor neuron disease: a systematic review. Palliat Support Care 2016; 14: 411-432.
 
25.
de Carvalho M, Chio A, Dengler R, Hecht M, Weber M, Swash M. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6: 17-28.
 
26.
Higashihara M, Sonoo M. Electrodiagnosis of ALS. Brain Nerve 2007; 59: 1031-1041.
 
27.
de Carvalho M, Turkman A, Swash M. Sensitivity of MUP parameters in detecting change in early ALS. Clin Neurophysiol 2014; 125: 166-169.
 
28.
Jacobsen AB, Kristensen RS, Witt A, Kristense AG, Duez L, Beniczky S, Fuglsang-Frederiksen A, Tankisi H. The utility of motor unit number estimation methodes versus quantitative motor unit potential analysis in diagnosis of ALS. Clin Neurophysiol 2018; 129: 646-653.
 
29.
de Carvalho M, Swash M. Fasciculation discharge frequency in amyotrophic lateralizacji sclerosis and related disorders. Clin Neurophysiol 2016; 127: 2257-2262.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top